Literature DB >> 26729876

Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence.

JoAnn M Tufariello1, Jessica R Chapman2, Christopher A Kerantzas3, Ka-Wing Wong4, Catherine Vilchèze5, Christopher M Jones6, Laura E Cole3, Emir Tinaztepe7, Victor Thompson7, David Fenyö8, Michael Niederweis6, Beatrix Ueberheide9, Jennifer A Philips10, William R Jacobs11.   

Abstract

Mycobacterium tuberculosis (Mtb) encodes five type VII secretion systems (T7SS), designated ESX-1-ESX-5, that are critical for growth and pathogenesis. The best characterized is ESX-1, which profoundly impacts host cell interactions. In contrast, the ESX-3 T7SS is implicated in metal homeostasis, but efforts to define its function have been limited by an inability to recover deletion mutants. We overcame this impediment using medium supplemented with various iron complexes to recover mutants with deletions encompassing select genes within esx-3 or the entire operon. The esx-3 mutants were defective in uptake of siderophore-bound iron and dramatically accumulated cell-associated mycobactin siderophores. Proteomic analyses of culture filtrate revealed that secretion of EsxG and EsxH was codependent and that EsxG-EsxH also facilitated secretion of several members of the proline-glutamic acid (PE) and proline-proline-glutamic acid (PPE) protein families (named for conserved PE and PPE N-terminal motifs). Substrates that depended on EsxG-EsxH for secretion included PE5, encoded within the esx-3 locus, and the evolutionarily related PE15-PPE20 encoded outside the esx-3 locus. In vivo characterization of the mutants unexpectedly showed that the ESX-3 secretion system plays both iron-dependent and -independent roles in Mtb pathogenesis. PE5-PPE4 was found to be critical for the siderophore-mediated iron-acquisition functions of ESX-3. The importance of this iron-acquisition function was dependent upon host genotype, suggesting a role for ESX-3 secretion in counteracting host defense mechanisms that restrict iron availability. Further, we demonstrate that the ESX-3 T7SS secretes certain effectors that are important for iron uptake while additional secreted effectors modulate virulence in an iron-independent fashion.

Entities:  

Keywords:  ESX-3; Mycobacterium tuberculosis; mycobactin; siderophore; type VII secretion system

Mesh:

Substances:

Year:  2016        PMID: 26729876      PMCID: PMC4725510          DOI: 10.1073/pnas.1523321113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  75 in total

1.  Mutually dependent secretion of proteins required for mycobacterial virulence.

Authors:  S M Fortune; A Jaeger; D A Sarracino; M R Chase; C M Sassetti; D R Sherman; B R Bloom; E J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-19       Impact factor: 11.205

2.  Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans.

Authors:  R Bellamy; C Ruwende; T Corrah; K P McAdam; H C Whittle; A V Hill
Journal:  N Engl J Med       Date:  1998-03-05       Impact factor: 91.245

3.  High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.

Authors:  Sandra Hervas-Stubbs; Laleh Majlessi; Marcela Simsova; Jana Morova; Marie-Jesus Rojas; Clémence Nouzé; Priscille Brodin; Peter Sebo; Claude Leclerc
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.

Authors:  Vasan K Sambandamurthy; Steven C Derrick; Tsungda Hsu; Bing Chen; Michelle H Larsen; Kripa V Jalapathy; Mei Chen; John Kim; Steven A Porcelli; John Chan; Sheldon L Morris; William R Jacobs
Journal:  Vaccine       Date:  2006-06-12       Impact factor: 3.641

5.  New use of BCG for recombinant vaccines.

Authors:  C K Stover; V F de la Cruz; T R Fuerst; J E Burlein; L A Benson; L T Bennett; G P Bansal; J F Young; M H Lee; G F Hatfull
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites.

Authors:  D Malo; K Vogan; S Vidal; J Hu; M Cellier; E Schurr; A Fuks; N Bumstead; K Morgan; P Gros
Journal:  Genomics       Date:  1994-09-01       Impact factor: 5.736

7.  SLC11A1 (formerly NRAMP1) gene polymorphisms and tuberculosis susceptibility: a meta-analysis.

Authors:  H T Li; T T Zhang; Y Q Zhou; Q H Huang; J Huang
Journal:  Int J Tuberc Lung Dis       Date:  2006-01       Impact factor: 2.373

8.  Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence.

Authors:  Priscille Brodin; Laleh Majlessi; Laurent Marsollier; Marien I de Jonge; Daria Bottai; Caroline Demangel; Jason Hinds; Olivier Neyrolles; Philip D Butcher; Claude Leclerc; Stewart T Cole; Roland Brosch
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

9.  Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.

Authors:  E Medina; R J North
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene.

Authors:  S Vidal; M L Tremblay; G Govoni; S Gauthier; G Sebastiani; D Malo; E Skamene; M Olivier; S Jothy; P Gros
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  74 in total

Review 1.  Phosphate responsive regulation provides insights for ESX-5 function in Mycobacterium tuberculosis.

Authors:  Sarah R Elliott; Anna D Tischler
Journal:  Curr Genet       Date:  2016-04-22       Impact factor: 3.886

Review 2.  Mycobacterium tuberculosis in the Face of Host-Imposed Nutrient Limitation.

Authors:  Michael Berney; Linda Berney-Meyer
Journal:  Microbiol Spectr       Date:  2017-06

3.  A New ESX-1 Substrate in Mycobacterium marinum That Is Required for Hemolysis but Not Host Cell Lysis.

Authors:  Rachel E Bosserman; Kathleen R Nicholson; Matthew M Champion; Patricia A Champion
Journal:  J Bacteriol       Date:  2019-06-21       Impact factor: 3.490

4.  Role of Metal-Dependent Regulation of ESX-3 Secretion in Intracellular Survival of Mycobacterium tuberculosis.

Authors:  Emir Tinaztepe; Jun-Rong Wei; Jenelle Raynowska; Cynthia Portal-Celhay; Victor Thompson; Jennifer A Philips
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

5.  Modulating Pathogenesis with Mobile-CRISPRi.

Authors:  Jiuxin Qu; Neha K Prasad; Michelle A Yu; Shuyan Chen; Amy Lyden; Nadia Herrera; Melanie R Silvis; Emily Crawford; Mark R Looney; Jason M Peters; Oren S Rosenberg
Journal:  J Bacteriol       Date:  2019-10-21       Impact factor: 3.490

Review 6.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

Review 7.  Type VII secretion systems: structure, functions and transport models.

Authors:  Angel Rivera-Calzada; Nikolaos Famelis; Oscar Llorca; Sebastian Geibel
Journal:  Nat Rev Microbiol       Date:  2021-05-26       Impact factor: 60.633

Review 8.  ESX secretion systems: mycobacterial evolution to counter host immunity.

Authors:  Matthias I Gröschel; Fadel Sayes; Roxane Simeone; Laleh Majlessi; Roland Brosch
Journal:  Nat Rev Microbiol       Date:  2016-09-26       Impact factor: 60.633

9.  PPE37 Is Essential for Mycobacterium tuberculosis Heme-Iron Acquisition (HIA), and a Defective PPE37 in Mycobacterium bovis BCG Prevents HIA.

Authors:  Michael V Tullius; Susana Nava; Marcus A Horwitz
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

10.  Mycobacterium tuberculosis Requires Regulation of ESX-5 Secretion for Virulence in Irgm1-Deficient Mice.

Authors:  Sarah R Elliott; Dylan W White; Anna D Tischler
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.